A large Scandinavian study reopens the debate on beta-blockers after myocardial infarction, revealing selective benefits.

A collaborative effort among international research teams provides the most definitive statement yet on the usefulness of ...

Please provide your email address to receive an email when new articles are posted on . Patients who received beta-blocker therapy reported higher anxiety, more frequent depressed mood and worse ...

In a recent study published in The New England Journal of Medicine, researchers conducted the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) ...

Madrid, Spain – 30 August 2025 : Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no ...

Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...

Beta-blockers provide no clinical benefit to post-MI patients with preserved left ventricular ejection fraction, according to a potentially paradigm-changing meta-analysis. The findings, published ...

Please provide your email address to receive an email when new articles are posted on . Beta-blocker therapy did not improve survival beyond 1 year after an MI, although a dose-dependent effect was ...

(HealthDay News) — For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), beta-blocker therapy at discharge correlates with ...

Credit: Getty Images. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. The role of beta-blockers after acute ...

Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no beta-blocker therapy in the subgroup of ...

Dallas, TX - With a good amount of data suggesting that many patients with heart failure aren't receiving all the evidence-based medical therapy recommended in the guidelines, perhaps it isn't ...